Correction to Lancet Microbe 2022; 3: e336–47

Stone W, Mahamar A, Smit MJ, et al. Single low-dose tafenoquine combined with dihydroartemisinin–piperaquine to reduce Plasmodium falciparum transmission in Ouelessebougou, Mali: a phase 2, single-blind, randomised clinical trial. Lancet Microbe 2022; 3: e336–47—In this Article, the date of the final follow-up visit in the final sentence of the Methods section in the Summary should have read “Dec 23, 2020”. This correction has been made as of Aug 11, 2022.